Treatment with Atorvastatin to the National Cholesterol Educational Program Goal Versus 'Usual' Care in Secondary Coronary Heart Disease Prevention

G. Athyros, Vasilios; A. Papageorgiou, Athanasios; R. Mercouris, Bodosakis; V. Athyrou, Valasia; N. Symeonidis, Athanasios; Basayannis, Elias; S. Demitriadis, Dimokritos; G. Kontopoulos, Athanasios

doi:10.1185/030079902125000787

Public

Treatment with Atorvastatin to the National Cholesterol Educational Program Goal Versus 'Usual' Care in Secondary Coronary Heart Disease Prevention

Published in Current Medical Research and Opinion • Jan 1, 2002

Authors:

Vasilios G. Athyros

Athanasios A. Papageorgiou

Bodosakis R. Mercouris

Abstract

BACKGROUND: Atorvastatin is very effective in reducing plasma low-density lipoprotein cholesterol (LDL-C) levels. However, there is no long-term survival study that evaluated this statin. PATIENTS-METHODS: To assess the effect of atorvastatin on morbidity and mortality (total and coronary) of patien...

Subject

Medicine

Atorvastatin

Myocardial infarction

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!